COMMUNIQUÉS West-GlobeNewswire

AI-Based Analysis of Dynamic Digital Radiography Data Gives Researchers Greater Insight into Lung Function and Pulmonary Disorders
23/05/2024
WAYNE, N.J., May 23, 2024 (GLOBE NEWSWIRE) -- In a landmark study, the latest in technology innovation by Konica Minolta Healthcare was used to develop a machine-learning-based analysis of X-ray imaging that [...]
Epic Bio to Participate in Fireside Chat at Stifel’s Genetic Medicines Forum
23/05/2024
SOUTH SAN FRANCISCO, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Epic Bio , a leading epigenetic editing company that plans to have its FSHD program enter the clinic this year, announced that Amber Salzman, Ph.D., chief [...]
Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting
23/05/2024
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) [...]
Aura Biosciences to Host Virtual KOL Event “Pioneering a New Standard of Care In Ocular Oncology” on May 29, 2024
23/05/2024
BOSTON, May 23, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to preserve the function of the [...]
Traws Pharma’s ICAR Poster Highlights Potency of COVID-19 Candidate
23/05/2024
Differentiated resistance profile positions Traws’ program as a potential class leader NEWTOWN, Pa., May 23, 2024 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (“Traws” or “Traws Pharma”), a clinical stage biopharmaceutical [...]
Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
23/05/2024
SEATTLE, May 23, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating [...]
CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments
23/05/2024
-Naimish Patel, M.D., appointed to Chief Medical Officer- -Julianne Bruno, M.B.A., promoted to Chief Operating Officer- ZUG, Switzerland and BOSTON, May 23, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a [...]
GeneType and Humanise Health host “Know Your Risk” Event
23/05/2024
PASADENA, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GeneType”), a global leader in genomics-based tests in health, wellness and serious disease, is [...]
Apogee Therapeutics to Participate in Upcoming June Investor Conferences
23/05/2024
SAN FRANCISCO and WALTHAM, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the treatment of atopic [...]
Rakovina Therapeutics Announces $1.5 million Non-Brokered Private Placement
23/05/2024
All monetary figures listed in Canadian Dollars. VANCOUVER, British Columbia, May 23, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or “Rakovina Therapeutics”) a biopharmaceutical [...]
Tourmaline Bio to Present at the Jefferies Global Healthcare Conference
23/05/2024
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients [...]
Pneumagen Presents Positive Phase 2 Influenza Human Challenge Study data on Neumifil, its Broad-Spectrum Antiviral Drug, at the American Thoracic Society (ATS) 2024 Conference
23/05/2024
Neumifil delivers statistically significant reductions in influenza symptomatic infection rate, symptom severity and viral load Strategy to advance clinical development of Neumifil to be based on these positive data and [...]
Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Protein Degradation in Focus Symposium
23/05/2024
PRESS RELEASE Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Protein Degradation in Focus Symposium First presentation of a novel mechanism of action for the [...]
Solei Brand Introduces New Cannabis-Infused ‘Warming Deep Tissue Stick’
23/05/2024
Solei’s New Cannabis-Infused Topical Solution is Made for Active Lifestyle Enthusiasts TORONTO, May 23, 2024 (GLOBE NEWSWIRE) -- May 23, 2024 – Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle [...]
TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing
23/05/2024
The Leidos team’s Next-Generation Medical Countermeasures (MCMs) Successfully Formulated with Company’s Proprietary Thin Film Freezing Technology MCM Candidates Demonstrated Chemical and Biological (CB) Neutralizing [...]
Hydreight Technologies through its associated Medical network now offer Tirzepatide to Product Offering which also features GLP-1 Medications (Low-Cost Semaglutide), NAD+ and more
23/05/2024
Tirzepatide, a dual GIP and GLP-1 receptor agonist (GIP/GLP-1 RA), is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss. The GLP-1 segment is an important class of drugs for [...]
Script Runner launches Canada’s first AI-powered drone delivery service, revolutionizing healthcare access for remote communities
23/05/2024
Thunder Bay test flight bridges healthcare gap; Canadian company prioritizes patient care with last-mile solutions THUNDER BAY, Ontario, May 23, 2024 (GLOBE NEWSWIRE) -- Script Runner, a health technology company that [...]
OneMedNet Reports Greater than Five-Fold Expansion of iRWD™ Network and Platform
23/05/2024
MINNEAPOLIS, May 23, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (“RWD”), inclusive of electronic health records [...]
ARCPOINT TO HOST CONFERENCE CALL TO DISCUSS 2024 Q1 FINANCIAL RESULTS
23/05/2024
Greenville, South Carolina, May 23, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) a leading US-based franchise system providing drug testing, alcohol screening, DNA and direct to [...]

Pages